Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center.

ABSTRACT: Paraneoplastic syndromes are rare conditions associated with characteristic autoantibodies produced by malignancy, although similar autoantibodies and clinical presentations may occur in the absence of any neoplasm. Testing for paraneoplastic syndromes often involves panels of autoantibody assays. While autoantibody testing may reveal or confirm actionable clinical diagnoses, inappropriate utilization of testing may be low yield and further lead to false positives that may confuse the clinical picture. There is thus opportunity to improve patient care by analyzing patterns of paraneoplastic autoantibody test utilization. The data in this article provides results from detailed retrospective review of patients tested by 7 autoantibody tests or test panels offered by two large reference labor

SUBMITTER: Krasowski MD 

PROVIDER: S-EPMC8627986 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature